As of Sep 01
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00. The median estimate represents a +95.06% increase from the last price of 7.69.
The current consensus among 2 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.